Coregistration of 18F-FDG-PET and MRI in the Staging of Potentially Resectable Hilar Cholangiocarcinoma: a Pilot Study

University of Toronto

Overview

To evaluate the feasibility and performance of coregistered 18F-FDG-PET/MRI in the staging of potentially respectable hilar cholangiocarcinoma.

Study Type

OBSERVATIONAL

Conditions

Cholangiocarcinoma

Eligibility

Sex: ALLMin age: 18 YearsMax age: 99 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Hilar cholangiocarcinoma assessed by conventional imaging modalities (triphasic CT scan of the liver) and thought to be potentially resectable. Exclusion Criteria: * Biliary drain inserted. * Contraindication for MRI. * Pregnant or breast-feeding. * Uncontrolled diabetes (over 9.7 mmol/L).

Locations (1)

UHN - Princess Margaret Hospital

Toronto, Ontario, Canada

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.